Global 5-Hydroxytryptamine Receptor Market Insights, Forecast to 2029

Publication ID:

PB503231694

Publication Date:

March 24, 2023

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Serotonin receptors are a group of g-protein-coupled receptors and ligand gated ion channels that occur in the central and peripheral nervous system. They regulate both excitatory and inhibitory neurotransmitters.
Market Analysis and Insights: Global 5-Hydroxytryptamine Receptor Market
The global 5-Hydroxytryptamine Receptor market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for 5-Hydroxytryptamine Receptor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for 5-Hydroxytryptamine Receptor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for 5-Hydroxytryptamine Receptor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of 5-Hydroxytryptamine Receptor include Adamed, Avineuro Pharmaceutical, Axovant Sciences, Biotie Therapies, Celon Pharma, Galenea Corp, H. Lundbeck, Reviva Pharmaceuticals and Suven Life Sciences, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for 5-Hydroxytryptamine Receptor market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of 5-Hydroxytryptamine Receptor, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for 5-Hydroxytryptamine Receptor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the 5-Hydroxytryptamine Receptor revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global 5-Hydroxytryptamine Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for 5-Hydroxytryptamine Receptor revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Adamed, Avineuro Pharmaceutical, Axovant Sciences, Biotie Therapies, Celon Pharma, Galenea Corp, H. Lundbeck, Reviva Pharmaceuticals and Suven Life Sciences, etc.
By Company
Adamed
Avineuro Pharmaceutical
Axovant Sciences
Biotie Therapies
Celon Pharma
Galenea Corp
H. Lundbeck
Reviva Pharmaceuticals
Suven Life Sciences
Teva Pharmaceutical Industries Ltd
Segment by Type
HTR6
HTR2B
Others
Segment by Application
Attention Deficit Hyperactivity Disorder
Psychiatric Disorders
Alzheimer's Disease
Chronic Obstructive Pulmonary Disease
Memory Impairment
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of 5-Hydroxytryptamine Receptor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 5-Hydroxytryptamine Receptor companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 5-Hydroxytryptamine Receptor revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global 5-Hydroxytryptamine Receptor Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 HTR6
1.2.3 HTR2B
1.2.4 Others
1.3 Market by Application
1.3.1 Global 5-Hydroxytryptamine Receptor Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Attention Deficit Hyperactivity Disorder
1.3.3 Psychiatric Disorders
1.3.4 Alzheimer's Disease
1.3.5 Chronic Obstructive Pulmonary Disease
1.3.6 Memory Impairment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global 5-Hydroxytryptamine Receptor Market Perspective (2018-2029)
2.2 Global 5-Hydroxytryptamine Receptor Growth Trends by Region
2.2.1 5-Hydroxytryptamine Receptor Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 5-Hydroxytryptamine Receptor Historic Market Size by Region (2018-2023)
2.2.3 5-Hydroxytryptamine Receptor Forecasted Market Size by Region (2024-2029)
2.3 5-Hydroxytryptamine Receptor Market Dynamics
2.3.1 5-Hydroxytryptamine Receptor Industry Trends
2.3.2 5-Hydroxytryptamine Receptor Market Drivers
2.3.3 5-Hydroxytryptamine Receptor Market Challenges
2.3.4 5-Hydroxytryptamine Receptor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue 5-Hydroxytryptamine Receptor by Players
3.1.1 Global 5-Hydroxytryptamine Receptor Revenue by Players (2018-2023)
3.1.2 Global 5-Hydroxytryptamine Receptor Revenue Market Share by Players (2018-2023)
3.2 Global 5-Hydroxytryptamine Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of 5-Hydroxytryptamine Receptor, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global 5-Hydroxytryptamine Receptor Market Concentration Ratio
3.4.1 Global 5-Hydroxytryptamine Receptor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by 5-Hydroxytryptamine Receptor Revenue in 2022
3.5 Global Key Players of 5-Hydroxytryptamine Receptor Head office and Area Served
3.6 Global Key Players of 5-Hydroxytryptamine Receptor, Product and Application
3.7 Global Key Players of 5-Hydroxytryptamine Receptor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 5-Hydroxytryptamine Receptor Breakdown Data by Type
4.1 Global 5-Hydroxytryptamine Receptor Historic Market Size by Type (2018-2023)
4.2 Global 5-Hydroxytryptamine Receptor Forecasted Market Size by Type (2024-2029)
5 5-Hydroxytryptamine Receptor Breakdown Data by Application
5.1 Global 5-Hydroxytryptamine Receptor Historic Market Size by Application (2018-2023)
5.2 Global 5-Hydroxytryptamine Receptor Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America 5-Hydroxytryptamine Receptor Market Size (2018-2029)
6.2 North America 5-Hydroxytryptamine Receptor Market Size by Type
6.2.1 North America 5-Hydroxytryptamine Receptor Market Size by Type (2018-2023)
6.2.2 North America 5-Hydroxytryptamine Receptor Market Size by Type (2024-2029)
6.2.3 North America 5-Hydroxytryptamine Receptor Market Share by Type (2018-2029)
6.3 North America 5-Hydroxytryptamine Receptor Market Size by Application
6.3.1 North America 5-Hydroxytryptamine Receptor Market Size by Application (2018-2023)
6.3.2 North America 5-Hydroxytryptamine Receptor Market Size by Application (2024-2029)
6.3.3 North America 5-Hydroxytryptamine Receptor Market Share by Application (2018-2029)
6.4 North America 5-Hydroxytryptamine Receptor Market Size by Country
6.4.1 North America 5-Hydroxytryptamine Receptor Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America 5-Hydroxytryptamine Receptor Market Size by Country (2018-2023)
6.4.3 North America 5-Hydroxytryptamine Receptor Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe 5-Hydroxytryptamine Receptor Market Size (2018-2029)
7.2 Europe 5-Hydroxytryptamine Receptor Market Size by Type
7.2.1 Europe 5-Hydroxytryptamine Receptor Market Size by Type (2018-2023)
7.2.2 Europe 5-Hydroxytryptamine Receptor Market Size by Type (2024-2029)
7.2.3 Europe 5-Hydroxytryptamine Receptor Market Share by Type (2018-2029)
7.3 Europe 5-Hydroxytryptamine Receptor Market Size by Application
7.3.1 Europe 5-Hydroxytryptamine Receptor Market Size by Application (2018-2023)
7.3.2 Europe 5-Hydroxytryptamine Receptor Market Size by Application (2024-2029)
7.3.3 Europe 5-Hydroxytryptamine Receptor Market Share by Application (2018-2029)
7.4 Europe 5-Hydroxytryptamine Receptor Market Size by Country
7.4.1 Europe 5-Hydroxytryptamine Receptor Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe 5-Hydroxytryptamine Receptor Market Size by Country (2018-2023)
7.4.3 Europe 5-Hydroxytryptamine Receptor Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China 5-Hydroxytryptamine Receptor Market Size (2018-2029)
8.2 China 5-Hydroxytryptamine Receptor Market Size by Type
8.2.1 China 5-Hydroxytryptamine Receptor Market Size by Type (2018-2023)
8.2.2 China 5-Hydroxytryptamine Receptor Market Size by Type (2024-2029)
8.2.3 China 5-Hydroxytryptamine Receptor Market Share by Type (2018-2029)
8.3 China 5-Hydroxytryptamine Receptor Market Size by Application
8.3.1 China 5-Hydroxytryptamine Receptor Market Size by Application (2018-2023)
8.3.2 China 5-Hydroxytryptamine Receptor Market Size by Application (2024-2029)
8.3.3 China 5-Hydroxytryptamine Receptor Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia 5-Hydroxytryptamine Receptor Market Size (2018-2029)
9.2 Asia 5-Hydroxytryptamine Receptor Market Size by Type
9.2.1 Asia 5-Hydroxytryptamine Receptor Market Size by Type (2018-2023)
9.2.2 Asia 5-Hydroxytryptamine Receptor Market Size by Type (2024-2029)
9.2.3 Asia 5-Hydroxytryptamine Receptor Market Share by Type (2018-2029)
9.3 Asia 5-Hydroxytryptamine Receptor Market Size by Application
9.3.1 Asia 5-Hydroxytryptamine Receptor Market Size by Application (2018-2023)
9.3.2 Asia 5-Hydroxytryptamine Receptor Market Size by Application (2024-2029)
9.3.3 Asia 5-Hydroxytryptamine Receptor Market Share by Application (2018-2029)
9.4 Asia 5-Hydroxytryptamine Receptor Market Size by Region
9.4.1 Asia 5-Hydroxytryptamine Receptor Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia 5-Hydroxytryptamine Receptor Market Size by Region (2018-2023)
9.4.3 Asia 5-Hydroxytryptamine Receptor Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Size by Type
10.2.1 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Size by Application
10.3.1 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Size by Country
10.4.1 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America 5-Hydroxytryptamine Receptor Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Adamed
11.1.1 Adamed Company Details
11.1.2 Adamed Business Overview
11.1.3 Adamed 5-Hydroxytryptamine Receptor Introduction
11.1.4 Adamed Revenue in 5-Hydroxytryptamine Receptor Business (2018-2023)
11.1.5 Adamed Recent Developments
11.2 Avineuro Pharmaceutical
11.2.1 Avineuro Pharmaceutical Company Details
11.2.2 Avineuro Pharmaceutical Business Overview
11.2.3 Avineuro Pharmaceutical 5-Hydroxytryptamine Receptor Introduction
11.2.4 Avineuro Pharmaceutical Revenue in 5-Hydroxytryptamine Receptor Business (2018-2023)
11.2.5 Avineuro Pharmaceutical Recent Developments
11.3 Axovant Sciences
11.3.1 Axovant Sciences Company Details
11.3.2 Axovant Sciences Business Overview
11.3.3 Axovant Sciences 5-Hydroxytryptamine Receptor Introduction
11.3.4 Axovant Sciences Revenue in 5-Hydroxytryptamine Receptor Business (2018-2023)
11.3.5 Axovant Sciences Recent Developments
11.4 Biotie Therapies
11.4.1 Biotie Therapies Company Details
11.4.2 Biotie Therapies Business Overview
11.4.3 Biotie Therapies 5-Hydroxytryptamine Receptor Introduction
11.4.4 Biotie Therapies Revenue in 5-Hydroxytryptamine Receptor Business (2018-2023)
11.4.5 Biotie Therapies Recent Developments
11.5 Celon Pharma
11.5.1 Celon Pharma Company Details
11.5.2 Celon Pharma Business Overview
11.5.3 Celon Pharma 5-Hydroxytryptamine Receptor Introduction
11.5.4 Celon Pharma Revenue in 5-Hydroxytryptamine Receptor Business (2018-2023)
11.5.5 Celon Pharma Recent Developments
11.6 Galenea Corp
11.6.1 Galenea Corp Company Details
11.6.2 Galenea Corp Business Overview
11.6.3 Galenea Corp 5-Hydroxytryptamine Receptor Introduction
11.6.4 Galenea Corp Revenue in 5-Hydroxytryptamine Receptor Business (2018-2023)
11.6.5 Galenea Corp Recent Developments
11.7 H. Lundbeck
11.7.1 H. Lundbeck Company Details
11.7.2 H. Lundbeck Business Overview
11.7.3 H. Lundbeck 5-Hydroxytryptamine Receptor Introduction
11.7.4 H. Lundbeck Revenue in 5-Hydroxytryptamine Receptor Business (2018-2023)
11.7.5 H. Lundbeck Recent Developments
11.8 Reviva Pharmaceuticals
11.8.1 Reviva Pharmaceuticals Company Details
11.8.2 Reviva Pharmaceuticals Business Overview
11.8.3 Reviva Pharmaceuticals 5-Hydroxytryptamine Receptor Introduction
11.8.4 Reviva Pharmaceuticals Revenue in 5-Hydroxytryptamine Receptor Business (2018-2023)
11.8.5 Reviva Pharmaceuticals Recent Developments
11.9 Suven Life Sciences
11.9.1 Suven Life Sciences Company Details
11.9.2 Suven Life Sciences Business Overview
11.9.3 Suven Life Sciences 5-Hydroxytryptamine Receptor Introduction
11.9.4 Suven Life Sciences Revenue in 5-Hydroxytryptamine Receptor Business (2018-2023)
11.9.5 Suven Life Sciences Recent Developments
11.10 Teva Pharmaceutical Industries Ltd
11.10.1 Teva Pharmaceutical Industries Ltd Company Details
11.10.2 Teva Pharmaceutical Industries Ltd Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd 5-Hydroxytryptamine Receptor Introduction
11.10.4 Teva Pharmaceutical Industries Ltd Revenue in 5-Hydroxytryptamine Receptor Business (2018-2023)
11.10.5 Teva Pharmaceutical Industries Ltd Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Adamed
Avineuro Pharmaceutical
Axovant Sciences
Biotie Therapies
Celon Pharma
Galenea Corp
H. Lundbeck
Reviva Pharmaceuticals
Suven Life Sciences
Teva Pharmaceutical Industries Ltd

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂